Combining Genetic Variants to Improve Risk Prediction for NAFLD and Its Progression to Cirrhosis: A Proof of Concept Study
Background & Aims. Identifying NAFLD patients at risk of progression is crucial to orient medical care and resources. We aimed to verify if the effects determined by different single nucleotide polymorphisms (SNPs) could add up to multiply the risk of NAFLD and NASH-cirrhosis. Methods. Three stu...
Saved in:
Main Authors: | , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-01-01
|
Series: | Canadian Journal of Gastroenterology and Hepatology |
Online Access: | http://dx.doi.org/10.1155/2018/7564835 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832552811704877056 |
---|---|
author | Umberto Vespasiani-Gentilucci Chiara Dell’Unto Antonio De Vincentis Andrea Baiocchini Marco Delle Monache Roberto Cecere Adriano Maria Pellicelli Valerio Giannelli Simone Carotti Giovanni Galati Paolo Gallo Francesco Valentini Franca Del Nonno Davide Rosati Sergio Morini Raffaele Antonelli-Incalzi Antonio Picardi |
author_facet | Umberto Vespasiani-Gentilucci Chiara Dell’Unto Antonio De Vincentis Andrea Baiocchini Marco Delle Monache Roberto Cecere Adriano Maria Pellicelli Valerio Giannelli Simone Carotti Giovanni Galati Paolo Gallo Francesco Valentini Franca Del Nonno Davide Rosati Sergio Morini Raffaele Antonelli-Incalzi Antonio Picardi |
author_sort | Umberto Vespasiani-Gentilucci |
collection | DOAJ |
description | Background & Aims. Identifying NAFLD patients at risk of progression is crucial to orient medical care and resources. We aimed to verify if the effects determined by different single nucleotide polymorphisms (SNPs) could add up to multiply the risk of NAFLD and NASH-cirrhosis. Methods. Three study populations, that is, patients diagnosed with NASH-cirrhosis or with noncirrhotic NAFLD and healthy controls, were enrolled. PNPLA3 rs738409, TM6SF2 rs58542926, KLF6 rs3750861, SOD2 rs4880, and LPIN1 rs13412852 were genotyped. Results. One hundred and seven NASH-cirrhotics, 93 noncirrhotic NAFLD, and 90 controls were enrolled. At least one difference in allele frequency between groups was significant, or nearly significant, for the PNPLA3, TM6SF2, and KLF6 variants (p<0.001, p<0.05, and p=0.06, resp.), and a risk score based on these SNPs was generated. No differences were observed for SOD2 and LPIN1 SNPs. When compared to a score of 0, a score of 1-2 quadrupled, and a score of 3-4 increased 20-fold the risk of noncirrhotic NAFLD; a score of 3-4 quadrupled the risk of NASH-cirrhosis. Conclusions. The effects determined by disease-associated variants at different loci can add up to multiply the risk of NAFLD and NASH-cirrhosis. Combining different disease-associated variants may represent the way for genetics to keep strength in NAFLD diagnostics. |
format | Article |
id | doaj-art-d4b60012130141539a87bcbfd040b534 |
institution | Kabale University |
issn | 2291-2789 2291-2797 |
language | English |
publishDate | 2018-01-01 |
publisher | Wiley |
record_format | Article |
series | Canadian Journal of Gastroenterology and Hepatology |
spelling | doaj-art-d4b60012130141539a87bcbfd040b5342025-02-03T05:57:46ZengWileyCanadian Journal of Gastroenterology and Hepatology2291-27892291-27972018-01-01201810.1155/2018/75648357564835Combining Genetic Variants to Improve Risk Prediction for NAFLD and Its Progression to Cirrhosis: A Proof of Concept StudyUmberto Vespasiani-Gentilucci0Chiara Dell’Unto1Antonio De Vincentis2Andrea Baiocchini3Marco Delle Monache4Roberto Cecere5Adriano Maria Pellicelli6Valerio Giannelli7Simone Carotti8Giovanni Galati9Paolo Gallo10Francesco Valentini11Franca Del Nonno12Davide Rosati13Sergio Morini14Raffaele Antonelli-Incalzi15Antonio Picardi16Internal Medicine, Geriatrics, and Hepatology Unit, University Campus Bio-Medico, Rome, ItalyInternal Medicine, Geriatrics, and Hepatology Unit, University Campus Bio-Medico, Rome, ItalyInternal Medicine, Geriatrics, and Hepatology Unit, University Campus Bio-Medico, Rome, ItalyLaboratory of Pathology of The National Institute for Infectious Diseases, Lazzaro Spallanzani, Rome, ItalyHepatology Outpatient Clinic, Colleferro Hospital, Rome, ItalyHepatology Outpatient Clinic, Colleferro Hospital, Rome, ItalyLiver Disease Unit, San Camillo-Forlanini Hospital, Rome, ItalyLiver Disease Unit, San Camillo-Forlanini Hospital, Rome, ItalyLaboratory of Microscopic and Ultrastructural Anatomy, CIR, University Campus Bio-Medico, Rome, ItalyInternal Medicine, Geriatrics, and Hepatology Unit, University Campus Bio-Medico, Rome, ItalyInternal Medicine, Geriatrics, and Hepatology Unit, University Campus Bio-Medico, Rome, ItalyInternal Medicine, Geriatrics, and Hepatology Unit, University Campus Bio-Medico, Rome, ItalyLaboratory of Pathology of The National Institute for Infectious Diseases, Lazzaro Spallanzani, Rome, ItalyUniversity La Sapienza of Rome, Rome, ItalyLaboratory of Microscopic and Ultrastructural Anatomy, CIR, University Campus Bio-Medico, Rome, ItalyInternal Medicine, Geriatrics, and Hepatology Unit, University Campus Bio-Medico, Rome, ItalyInternal Medicine, Geriatrics, and Hepatology Unit, University Campus Bio-Medico, Rome, ItalyBackground & Aims. Identifying NAFLD patients at risk of progression is crucial to orient medical care and resources. We aimed to verify if the effects determined by different single nucleotide polymorphisms (SNPs) could add up to multiply the risk of NAFLD and NASH-cirrhosis. Methods. Three study populations, that is, patients diagnosed with NASH-cirrhosis or with noncirrhotic NAFLD and healthy controls, were enrolled. PNPLA3 rs738409, TM6SF2 rs58542926, KLF6 rs3750861, SOD2 rs4880, and LPIN1 rs13412852 were genotyped. Results. One hundred and seven NASH-cirrhotics, 93 noncirrhotic NAFLD, and 90 controls were enrolled. At least one difference in allele frequency between groups was significant, or nearly significant, for the PNPLA3, TM6SF2, and KLF6 variants (p<0.001, p<0.05, and p=0.06, resp.), and a risk score based on these SNPs was generated. No differences were observed for SOD2 and LPIN1 SNPs. When compared to a score of 0, a score of 1-2 quadrupled, and a score of 3-4 increased 20-fold the risk of noncirrhotic NAFLD; a score of 3-4 quadrupled the risk of NASH-cirrhosis. Conclusions. The effects determined by disease-associated variants at different loci can add up to multiply the risk of NAFLD and NASH-cirrhosis. Combining different disease-associated variants may represent the way for genetics to keep strength in NAFLD diagnostics.http://dx.doi.org/10.1155/2018/7564835 |
spellingShingle | Umberto Vespasiani-Gentilucci Chiara Dell’Unto Antonio De Vincentis Andrea Baiocchini Marco Delle Monache Roberto Cecere Adriano Maria Pellicelli Valerio Giannelli Simone Carotti Giovanni Galati Paolo Gallo Francesco Valentini Franca Del Nonno Davide Rosati Sergio Morini Raffaele Antonelli-Incalzi Antonio Picardi Combining Genetic Variants to Improve Risk Prediction for NAFLD and Its Progression to Cirrhosis: A Proof of Concept Study Canadian Journal of Gastroenterology and Hepatology |
title | Combining Genetic Variants to Improve Risk Prediction for NAFLD and Its Progression to Cirrhosis: A Proof of Concept Study |
title_full | Combining Genetic Variants to Improve Risk Prediction for NAFLD and Its Progression to Cirrhosis: A Proof of Concept Study |
title_fullStr | Combining Genetic Variants to Improve Risk Prediction for NAFLD and Its Progression to Cirrhosis: A Proof of Concept Study |
title_full_unstemmed | Combining Genetic Variants to Improve Risk Prediction for NAFLD and Its Progression to Cirrhosis: A Proof of Concept Study |
title_short | Combining Genetic Variants to Improve Risk Prediction for NAFLD and Its Progression to Cirrhosis: A Proof of Concept Study |
title_sort | combining genetic variants to improve risk prediction for nafld and its progression to cirrhosis a proof of concept study |
url | http://dx.doi.org/10.1155/2018/7564835 |
work_keys_str_mv | AT umbertovespasianigentilucci combininggeneticvariantstoimproveriskpredictionfornafldanditsprogressiontocirrhosisaproofofconceptstudy AT chiaradellunto combininggeneticvariantstoimproveriskpredictionfornafldanditsprogressiontocirrhosisaproofofconceptstudy AT antoniodevincentis combininggeneticvariantstoimproveriskpredictionfornafldanditsprogressiontocirrhosisaproofofconceptstudy AT andreabaiocchini combininggeneticvariantstoimproveriskpredictionfornafldanditsprogressiontocirrhosisaproofofconceptstudy AT marcodellemonache combininggeneticvariantstoimproveriskpredictionfornafldanditsprogressiontocirrhosisaproofofconceptstudy AT robertocecere combininggeneticvariantstoimproveriskpredictionfornafldanditsprogressiontocirrhosisaproofofconceptstudy AT adrianomariapellicelli combininggeneticvariantstoimproveriskpredictionfornafldanditsprogressiontocirrhosisaproofofconceptstudy AT valeriogiannelli combininggeneticvariantstoimproveriskpredictionfornafldanditsprogressiontocirrhosisaproofofconceptstudy AT simonecarotti combininggeneticvariantstoimproveriskpredictionfornafldanditsprogressiontocirrhosisaproofofconceptstudy AT giovannigalati combininggeneticvariantstoimproveriskpredictionfornafldanditsprogressiontocirrhosisaproofofconceptstudy AT paologallo combininggeneticvariantstoimproveriskpredictionfornafldanditsprogressiontocirrhosisaproofofconceptstudy AT francescovalentini combininggeneticvariantstoimproveriskpredictionfornafldanditsprogressiontocirrhosisaproofofconceptstudy AT francadelnonno combininggeneticvariantstoimproveriskpredictionfornafldanditsprogressiontocirrhosisaproofofconceptstudy AT daviderosati combininggeneticvariantstoimproveriskpredictionfornafldanditsprogressiontocirrhosisaproofofconceptstudy AT sergiomorini combininggeneticvariantstoimproveriskpredictionfornafldanditsprogressiontocirrhosisaproofofconceptstudy AT raffaeleantonelliincalzi combininggeneticvariantstoimproveriskpredictionfornafldanditsprogressiontocirrhosisaproofofconceptstudy AT antoniopicardi combininggeneticvariantstoimproveriskpredictionfornafldanditsprogressiontocirrhosisaproofofconceptstudy |